• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during pregnancy and nursing is a challenge for women suffering from the condition. There are few data on how exposure to ADHD for a long time could affect a foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological disorders such as impaired vision or hearing, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication need to weigh the benefits of taking it against the potential dangers for the fetus. The doctors don't have the information to give clear advice, but can provide information on the risks and benefits to assist pregnant women to make an informed decision.

A study published in Molecular Psychiatry found that women who used ADHD medications in early pregnancy did not face a significantly increased risk of fetal heart malformations or major structural birth defects. Researchers conducted a massive population-based case control study to assess the frequency of structural defects that were major in infants born to mothers who took stimulants during pregnancy. Clinical geneticists and pediatric cardiologists looked over the cases to ensure an accurate classification of the cases and to reduce the possibility of bias.

However, the researchers' study had its limitations. The most popular adhd medication important issue was that they were not able to differentiate the effects of the medication from the disorder at hand. This makes it difficult to know whether the limited associations observed in the exposed groups are due to the use of medication or comorbidities that cause confusion. The researchers also did not look at long-term outcomes for offspring.

The study did show that infants whose mothers had taken ADHD medication during pregnancy were at slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or cut back on their medications prior to or during pregnancy. The reason for this was central nervous system-related disorders, and the increased risk for admission did not appear to be affected by the type of stimulant medications were used during pregnancy.

Women who used stimulant ADHD medication during pregnancy also had an elevated chance of having a caesarean delivery or having a baby with a low Apgar score (less than 7). These risks did not appear to be affected by the kind of medication used during pregnancy.

Researchers suggest that the small risk of using ADHD medication during pregnancies in the early stages can be offset by greater benefits to both mother and baby of continuing treatment for the woman’s disorder. Physicians should talk to their patients about this and try to help them improve coping skills which can lessen the impact of her disorder in her daily life and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and being treated with medication, the dilemma of whether to continue or end treatment during pregnancy is a question that doctors are having to confront. These decisions are often taken without clear and authoritative evidence. Instead, physicians must take into account their own experience and experience, as well as the experiences of other doctors, and the research on the subject.

The issue of risk to infants is extremely difficult. The research that has been conducted on this topic is based on observation rather than controlled studies and a lot of the results are conflicting. Most studies focus on live births, which can underestimate the teratogenic impact that can lead to abortions or terminations of pregnancy. The study that is discussed in the journal club addresses these limitations by analyzing information on deceased and live births.

Conclusion A few studies have revealed a positive correlation between ADHD medications and certain birth defects, other studies have not shown such a relationship. The majority of studies show an unintended, or slightly negative, effect. In each case, a careful analysis of the benefits and risks must be performed.

It can be difficult, if not impossible, for women suffering from ADHD to stop taking their medication. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of loneliness. A decrease in medication could affect the ability to drive safely and to perform work-related tasks which are essential aspects of normal life for those with ADHD.

She suggests women who are uncertain about whether to continue or stop taking medication because of their pregnancy, consider educating family members, friends, and coworkers on the condition, its effects on daily functioning, and on the advantages of staying on the current treatment plan. Educating them can also make the woman feel more comfortable in her struggle with her decision. It is important to remember that certain medications can pass through the placenta so if the patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she should be aware of the possibility that traces of the medication could be transferred to the infant.

Risk of Birth Defects

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns over the impact that these drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. With two massive data sets researchers were able to analyze more than 4.3 million pregnancies to determine whether stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, the first trimester ADHD medication use was associated with slightly higher risk of certain heart defects, like ventriculoseptal defects.

The authors of the study didn't discover any link between early use of medication and congenital anomalies such as facial deformities or club feet. The findings are in line dealing with adhd without medication previous studies revealing a small but significant increase in the risk of heart malformations in women who started taking ADHD medications prior to the time of the birth of their child. This risk increased during the latter stages of pregnancy, when a lot of women decided to stop taking their medication.

Women who used ADHD medications during the first trimester of pregnancy were also more likely to undergo caesarean section, low Apgar score after delivery and a baby that required help breathing at birth. The researchers of the study were unable to eliminate selection bias because they limited their study to women without other medical conditions that could have contributed to the findings.

Researchers hope their research will help doctors when they meet pregnant women. They advise that while a discussion of risks and benefits is important, the decision to stop or keep treatment should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors caution that, although stopping the medication is a possibility to look into, it is not advised due to the high rate depression and other mental disorders among women who are pregnant or recently gave birth. Further, research shows that women who stop taking their medication will have a difficult adjustment to life without them once the baby is born.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women with intuniv adhd medication who have to deal with their symptoms while attending physician appointments, making preparations for the arrival of a baby and adapting to new routines in the home are often faced with a number of difficulties. Many women decide to continue taking their best adhd medication for adults medication during pregnancy.

The risk to breastfeeding infant is not too high since the majority of stimulant medications passes through breast milk at low levels. However, the frequency of exposure to medications by the newborn can vary depending on the dosage, frequency it is administered, and the time of the day the medication is administered. Additionally, individual medications enter the infant's system differently through the gastrointestinal tract and breast milk, and the effect of this on a newborn is not fully understood.

Some physicians may discontinue stimulant medication during a woman's pregnancy due to the lack of research. This is a complicated decision for the patient, who must balance the benefit of continuing her medication with the potential dangers to the foetus. Until more information becomes available, Most Popular Adhd Medication GPs can ask pregnant patients whether they have a background of ADHD or if they are planning to take medication in the perinatal phase.

A increasing number of studies have proven that women can continue to take their ADHD medication during pregnancy and breastfeeding. In response, an increasing number of patients are opting to do so. They have found after consulting with their physicians, that the benefits of keeping their current medication outweigh possible risks.

Women with ADHD who are planning to nurse should seek the advice of an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation should also be provided to help pregnant women suffering from ADHD understand their symptoms and the underlying disorder, learn about available treatments and to reinforce existing coping strategies. This should be a multidisciplinary effort together with obstetricians, GPs and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother and child, monitoring of indicators of deterioration, and, if needed adjustments to the medication regime.